Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Curtis Mabilangan"'
Autor:
Alexandra Seal, Michael Hawkes, Ravi Bhargava, Michelle Noga, Jutta Preiksaitis, Curtis Mabilangan, Joan Robinson
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0167922 (2017)
Recipients of solid organ transplants (SOT) have extensive diagnostic imaging (DI). The purpose of this study was to quantify this exposure. Children from northern Alberta with SOTs at Stollery Children's Hospital, Edmonton, Alberta January 1, 2006,
Externí odkaz:
https://doaj.org/article/0a95ea61ddbc43d7880255e54044239b
Autor:
Ryan J. Stubbins, Ryan Lam, James Zhu, Sunita Ghosh, Curtis Mabilangan, John Kuruvilla, Rashmi S Goswami, Raymond Lai, Jutta K Preiksaitis, Michael D Jain, Anthea C Peters
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:744-752
The tumor microenvironment (TME) in post-transplant lymphoproliferative disorders (PTLDs) remains unexplored. Tumor infiltrating lymphocytes (TILs) are prognostic in other lymphomas. We assessed the prognostic impact of TILs in monomorphic B-cell PTL
Autor:
Cristina Hernandez, Curtis Mabilangan, Catherine Burton, Jutta K. Preiksaitis, Karen Doucette
Publikováno v:
American Journal of Transplantation. 21:3958-3970
Although antiviral prophylaxis has reduced cytomegalovirus (CMV) DNAemia and disease in seronegative solid organ transplant (SOT) recipients (R-) receiving seropositive donor organs (D+), its impact on CMV transmission is uncertain. Transmission, def
Autor:
Catherine Burton, Jutta K. Preiksaitis, Sheila F. O'Brien, Curtis Mabilangan, Susan Nahirniak
Publikováno v:
American Journal of Transplantation. 20:3509-3519
Solid organ transplant (SOT) recipients who are cytomegalovirus (CMV) seronegative (R-) and receive seronegative donor (D-) organs have a small but currently unquantified risk of both transfusion-transmitted CMV (TT-CMV) and community-acquired CMV (C
Autor:
Jutta K. Preiksaitis, Curtis Mabilangan, Sabrina Plitt, Catherine Burton, Sheila F. O'Brien, Dean T. Eurich
Publikováno v:
J Assoc Med Microbiol Infect Dis Can
Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections are common, causing significant morbidity in pregnancy (congenital CMV) and transplant recipients (CMV, EBV). Canadian prevalence data are needed to model disease burden and develop strate
Publikováno v:
The Journal of Infectious Diseases. 223:827-837
Background The epidemiology of single versus multiple cytomegalovirus (CMV) strain transmission from donor (D+) to seronegative solid organ transplant (SOT) recipients (R−) is uncertain, as is whether “relapsing” recipient infection represents
Publikováno v:
The Journal of Infectious Diseases. 215:1094-1101
BACKGROUND. Whether cytomegalovirus (CMV) DNA exists in plasma as virion-associated or free DNA is uncertain. METHODS. An assay combining DNase I digestion and CMV quantitative polymerase chain reaction (DNase-CMV-qPCR) was developed to differentiate
Autor:
Cristina Hernandez, Dima Kabbani, Carlos Cervera, Ali Kapasi, Jutta K. Preiksaitis, A. Hirji, Sanjaya Chandrarathne, Harjot Malhi, Kieran Halloran, Dale Lien, Curtis Mabilangan, Justin Weinkauf
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation SocietyREFERENCES. 21(4)
Background Universal antiviral prophylaxis is the preferred preventive strategy for lung transplant recipients (LTRs) at risk of CMV infection. We compared the risk of CMV infection between CMV D+/R + and D-/R + LTRs after 3 months of prophylaxis. Me
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation Society. 21(1)
Some studies have shown that pre-transplant cytomegalovirus (CMV) serostatus is associated with heart transplant patient survival while others have not. We analyzed the relationship between pre-transplant donor/recipient CMV serostatus and long-term
Autor:
Catherine Burton, Vito Scalia, Curtis Mabilangan, Jutta K. Preiksaitis, Sheila F. O'Brien, Margaret Fearon, Tatiana Dragan
Publikováno v:
Pediatric transplantation. 22(5)
Assignment of CMV infection status in infants awaiting SOT is challenging as passive maternal antibody can lead to false-positive serology. Since 2000, our protocol has recommended sending throat and urine samples for CMV viral detection, culture, or